Structure |
Chemical Name |
CAS |
MF |
|
ent-Ivabradine Hydrochloride |
167072-91-5 |
C27H36N2O5 |
|
SofosBuvir Impurity 2 |
|
|
|
isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
1346238-10-5 |
C19H22N2O3S |
|
1,3-diphenylpropan-1-ol |
14097-24-6 |
C15H16O |
|
Canagliflozin Impurity 21 |
|
|
|
Canagliflozin Impurity 7 |
|
|
|
Fasudil Impurity 5 |
2044702-91-0 |
C10H9NO3S |
|
Ibrutinib Impurity 10 |
|
|
|
Lesinurad Impurity 4 |
1533519-97-9 |
C17H14BrN3O2S |
|
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
1610043-62-3 |
C12H13FN2 |
|
FeBuxostat Impurity 26 |
1886961-39-2 |
C14H12N2O3S |
|
Rivaroxaban degradation impurity 2 |
|
|
|
(S)-methyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1911578-88-5 |
C16H13F5NO5P |
|
(R)-3-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium |
|
C19H28NO3+ |
|
5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidine-2,4(1H,3H)-dione |
|
C8H9FN2O4S |
|
Amlodipine Impurity 13 |
|
C26H31ClN2O8S |
|
Cefathiamidine Impurity 3 |
1417570-09-2 |
C17H26N4O4S2 |
|
Rivaroxaban Impurity 34 |
|
|
|
Rivaroxaban Impurity 43 |
2197189-38-9 |
C19H18ClN3O6S |
|
(S)-thiazolidine-4-carboxylic acid (D) |
|
C4H7NO2S |
|
Clindamycin 2,4-Diphosphate |
1309048-48-3 |
C18H35ClN2O11P2S |
|
1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethan-1-amine hydrochloride |
154377-56-7 |
C12H17N |
|
Brexpiprazole Impurity 20 |
1420987-85-4 |
C20H20N2S2 |
|
Cabozantinib Impurity D |
|
|
|
4,9-diisobutyl-1,6-diazecane-2,7-dione |
1990538-03-8 |
C16H30N2O2 |
|
ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate |
75073-15-3 |
C12H9ClFNO3 |
|
5-phenyl-1H-pyrrole-3-carbonitrile |
122453-85-4 |
C11H8N2 |
|
2-メチル-4,5-ジニトロ-1H-イミダゾール |
19183-16-5 |
C4H4N4O4 |
|
1-[2-ヒドロキシ-3-(2-メトキシフェノキシ)プロピル]ピペラジン |
162712-35-8 |
C14H22N2O3 |
|
3,5-Pyridinedicarboxylicacid, 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester |
34148-67-9 |
C19H22ClNO4 |
|
シドキセピン塩酸塩 |
25127-31-5 |
C19H22ClNO |
|
Phenol, 4-(hydroxyamino)- |
3505-87-1 |
C6H7NO2 |
|
Benzoic acid, 4-(3-hydroxy-1-propenyl)-, ethyl ester |
89113-43-9 |
C12H14O3 |
|
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
2041584-99-8 |
C10H13FN2O5 |
|
Dapoxetine Impurity 13 |
156453-50-8 |
C19H18O2 |
|
Terbutaline Impurity 4 |
52144-92-0 |
C33H35NO3 |
|
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine |
1823404-28-9 |
C9H11BrClN3 |
|
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid |
1714147-47-3 |
C25H36CaFN3O7S |
|
N-(2,6-dimethylphenyl)nicotinamide |
84951-65-5 |
C14H14N2O |
|
Tirofiban hydrochloride Impurity 6 |
2250244-31-4 |
C17H27NO7S2 |
|
Demiditraz IMpurity |
944268-65-9 |
C20H20N2 |
|
Blonanserin impurity H |
|
|
|
Captopril impurity 1 |
|
|
|
Cefodizime Impurity 6 |
|
|
|
Clindamycin Impurity 5 |
|
|
|
Dapoxetine Impurity 16 |
|
|
|
Doxofylline Impurity 5 |
|
|
|
Everolimus impurity B |
|
|
|
FeBuxostat Impurity 27 |
|
|
|
Fosaprepitant Impurity 1 |
172822-01-4 |
C23H22F7N4O6P |
|
Hydroxychloroquine Impurity 7 |
47493-14-1 |
C20H28ClN3O2 |
|
Indacaterol Impurity 12 |
1026461-20-0 |
C22H24N2O3 |
|
Isavuconazole Impurity 15 |
|
|
|
Isavuconazole Impurity 3 |
|
|
|
Isavuconazole Impurity 8 |
|
|
|
Lenvatinib Impurity 3 |
|
|
|
Linagliptin Impurity 44 |
|
|
|
MiraBegron impurity E |
|
|
|
Moxifloxacin Impurity 16 |
|
|
|
Nifedipine Impurity H |
74936-71-3 |
C16H16N2O6 |
|
Plerixafor Impurity 3 |
|
|
|
Posaconazole Impurity 27 |
|
|
|
Posaconazole Impurity 44 |
357189-97-0 |
C21H20F2N4O3 |
|
Pramipexole Impurity 10 |
|
|
|
rac N-Propyl-2-cyanimidopyrrolidine-5-acetic Acid |
|
|
|
sofosBuvir Impurity 33 |
|
|
|
sofosBuvir impurity 49 |
|
|
|
SofosBuvir Impurity 55 |
|
|
|
Tenofovir Impurity W |
1244022-55-6 |
C15H24N5O8P |
|
TerButaline Ep Impurity B |
|
|
|
Timolol EP Impurity H |
158636-97-6 |
C13H24N4O3S |
|
Tirofiban Impurity 11 |
|
|
|
Tofacitinib Impurity 45 |
2407039-29-4 |
C16H20N6O2 |
|
Tofacitinib impurity S |
|
|
|
Trelagliptin Impurity 25 |
|
|
|
L-アラニン2-(2-アミノ-6-オキソ-1,6-ジヒドロ-9H-プリン-9-イルメトキシ)エチル |
84499-64-9 |
C11H16N6O4 |
|
Lidocaine EP Impurity F |
142713-08-4 |
C14H22N2O |
|
Ampicillin Impurity P |
|
|
|
Cefdinir Impurity B (CP) |
|
|
|
Cloxacillin Impurity A |
|
|
|
EM-201 |
857839-61-3 |
C37H65NO12 |
|
(4R,5S,6S)-6-[(R)-1-ヒドロキシエチル]-4-メチル-7-オキソ-3-[[(3S,5S)-5-[(ジメチルアミノ)カルボニル]-1-[[(1S,2R)-1-[[2,3-ジヒドロ-5-カルボキシ-3β-メチル-4-[[5β-[(ジメチルアミノ)カルボニル]ピロリジン-3β-イル]チオ]-1H-ピロール]-2β-イル]-2-ヒドロキシプロピル]カルボニル]ピロリジン-3-イル]チオ]-1-アザビシクロ[3.2.0]ヘプタ-2-エン-2-カルボン酸 |
166901-45-7 |
C34H50N6O10S2 |
|
Oxacillin Sodium Impurity D(EP) |
1642559-63-4 |
C18H21N3O4S |
|
Oxacillin Sodium Impurity J(EP) |
|
|
|
Spectinomycin Impurity A |
|
|
|
Gabapentin EP Impurity G |
1500558-49-5 |
C10H19NO2 |
|
2-butyrylbenzoic acid |
19666-03-6 |
C11H12O3 |
|
Cefminox sodium impurities D |
|
|
|
(R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide |
1879903-65-7 |
C19H18ClN3O5S |
|
Cefmetazole impurity |
56796-19-1 |
C28H27N7O5S3 |
|
3-ethylisobenzofuran-1(3H)-one |
17475-41-1 |
C10H10O2 |
|
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
|
Moxifloxacin EP Impurity C HCl |
|
|
|
Moxifloxacin Impurity 23 |
855661-74-4 |
C21H24FN3O4 |
|
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
|
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
|
Tofacitinib Related Compound |
1206824-85-2 |
C10H18ClN3O |
|
Fluvastatin EP impurity A -G |
93957-58-5 |
C24H26FNO4 |
|
PWKRNMKZGWGSDV-UHFFFAOYSA-N |
1422960-88-0 |
C33H34ClN4+ |
|
sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate |
1329502-92-2 |
C33H41N4NaO7 |